Jubilant Pharmova Limited

NSE: JUBLPHARMA

Compare with…

Employs 5,657 permanent employees and workers, 2.0% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹196 cr.

Headcount

Annual, from the BRSR filed with NSE (as of 31 March each year)

Permanent
Contract / other
As ofScopePermanentChange (%)Contract / otherChange (%)
31 Mar 2023Group4,360—644—
31 Mar 2024Group5,3991,039(23.8%)351−293(45.5%)
31 Mar 2025Group5,547148(2.7%)542191(54.4%)
31 Mar 2026Group5,657110(2.0%)729187(34.5%)

Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.

Financials (₹ cr)

Revenue (₹ cr)
Employee cost (₹ cr)
Net profit (₹ cr)
PeriodRevenue (₹ cr)Change (%)Employee cost (₹ cr)Change (%)Net profit (₹ cr)Change (%)Flags
Quarter ended 31 Dec 202419630(18.3%)521(1.4%)5−5(49.5%)
Quarter ended 30 Sept 2024166−1(0.6%)513(5.5%)1121(202.9%)
Quarter ended 30 Jun 2024167−39(19.0%)492(4.7%)-10−43(131.4%)
Quarter ended 31 Mar 202420631(17.5%)47−3(6.8%)3335(1454.2%)
Quarter ended 31 Dec 2023175−11(6.0%)504(8.2%)-2−2(500.0%)
Quarter ended 30 Sept 2023186−31(14.3%)46−1(2.9%)-0−2(121.0%)
Quarter ended 30 Jun 202321718(8.8%)487(18.5%)233(106.2%)
Quarter ended 31 Mar 202320017(9.4%)40−3(6.6%)-31−25(423.9%)
Quarter ended 31 Dec 2022183154(534.7%)4330(229.1%)-6−3(89.4%)⚠
Quarter ended 31 Mar 20222910(54.2%)13−0(0.5%)-32(41.8%)⚠
Quarter ended 31 Dec 202119−1(6.8%)131(11.5%)-5−93(106.1%)⚠
Quarter ended 30 Sept 202120−0(1.1%)120(3.8%)8889(7894.7%)⚠
Quarter ended 30 Jun 202120−346(94.5%)11−23(67.5%)-1−36(103.2%)⚠
Quarter ended 31 Mar 2021366—35—35—⚠